---
document_datetime: 2023-09-21 17:09:27
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/elaprase-epar-all-authorised-presentations_en.pdf
document_name: elaprase-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8931822
conversion_datetime: 2025-12-17 09:02:36.613966
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form                   | Route of        | Packaging    | Content   | Package size   |
|-----------------|-----------------|------------|---------------------------------------|-----------------|--------------|-----------|----------------|
| EU/1/06/365/001 | Elaprase        | 2 mg/ml    | Concentrate for solution for infusion | Intravenous use | Vial (glass) | 3 ml      | 1 vial         |
| EU/1/06/365/002 | Elaprase        | 2 mg/ml    | Concentrate for solution for infusion | Intravenous use | Vial (glass) | 3 ml      | 4 vials        |
| EU/1/06/365/003 | Elaprase        | 2 mg/ml    | Concentrate for solution for infusion | Intravenous use | Vial (glass) | 3 ml      | 10 vials       |